Copyright
©The Author(s) 2017.
World J Gastroenterol. Sep 21, 2017; 23(35): 6412-6419
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6412
Table 1 Body weight in each group at wk 8, 10 and 12
| Group | Body weighting | ||
| 8 wk | 10 wk | 12 wk | |
| Healthy control group, A | 510 | 536 | 527 |
| TAA group, B | 394 | 401 | 454 |
| TAA + low-dose aspirin group, C | 381 | 403 | 403 |
| TAA + high-dose aspirin group, D | 381 | 364 | 408 |
| TAA + enoxaparin group, E | 385 | 409 | 415 |
- Citation: Li CJ, Yang ZH, Shi XL, Liu DL. Effects of aspirin and enoxaparin in a rat model of liver fibrosis. World J Gastroenterol 2017; 23(35): 6412-6419
- URL: https://www.wjgnet.com/1007-9327/full/v23/i35/6412.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i35.6412